News

Ophthalmology Times11d
Expanding access, enhancing research: The evolving landscape of ophthalmic clinical trials
The ophthalmic drug development industry is undergoing significant transformation, marked by unprecedented advancements in ...
FierceBiotech7mon
EQBMED publishes self-assessment tool for trial diversity
The academic-led, industry-partnered collaboration Equitable Breakthroughs in Medicine Development (EQBMED) has released an assessment tool for clinical trial sites to evaluate their ability to ...
Morningstar2mon
Clearmind Medicine Announces First U.S. Clinical Site Initiation for CMND-100 Clinical Trial in Patients with Alcohol Use Disorder - Morningstar
Clearmind Medicine Announces First U.S. Clinical Site Initiation for CMND-100 Clinical Trial in Patients with Alcohol Use Disorder Provided by GlobeNewswire Apr 10, 2025, 12:25:00 PM ...
Yahoo Finance2mon
CERo Therapeutics Holdings, Inc. Announces Sarah Cannon Research Institute at Colorado Blood Cancer Institute as Key Clinical Trial Site for its Phase 1 Clinical Trial of CER ...
SOUTH SAN FRANSCISCO, Calif, April 24, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to ...